HHS grants

Open and forecast HHS opportunities

From Grants.gov, soonest deadline first.

1. Closes22 OCT

   Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)

   NIH · Nonprofits, Tribes, School districts, +12 more

   NIMH seeks applications for pilot research to adapt, optimize, and test behavioral interventions that address common sleep problems in adolescents and young adults with or at risk for a mental health disorder. This notice of funding opportunity (NOFO) supports pilot clinical trials designed to evaluate the feasibility, tolerability, acceptability, safety, an

   Closes tomorrow$1.5 million in total

   SaveCalendar
2. Closes26 OCT

   Long-term health outcomes of people living with spina bifida

   CDC · Counties, Private colleges, Cities and towns, +9 more

   The purpose of component A (8-11 awardees) of this NOFO is to collect high-quality longitudinal data on children and adults with spina bifida (SB) who receive care in specialized spina bifida clinics participating in the National Spina Bifida Patient Registry (NSBPR). The purpose of component B (6-8 awardees) is to implement and evaluate the Urologic Managem

   Closes in 5 days$100,000 to $300,000

   SaveCalendar
3. Closes30 OCT

   GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)

   NIH · School districts, Tribal organizations, Nonprofits, +12 more

   The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Fundin

   Closes in 9 daysUp to $1.3 million

   SaveCalendar
4. Closes30 OCT

   GREGoRi Innovation Projects (U01 Clinical Trial Optional)

   NIH · Special districts, Public colleges, Tribal organizations, +12 more

   The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. This Notice of Funding Opportunity i

   Closes in 9 days$3 to $500,000

   SaveCalendar
5. Closes30 OCT

   GREGoRi Technology Integration Center (U01, Clinical Trials Optional)

   NIH · Housing authorities, For-profits, School districts, +12 more

   The Genomics Research to Elucidate the Genetics of Rare Diseases:innovation (GREGoRi) initiative seeks to accelerate a paradigm shift in rare disease diagnosis by reimagining the tools, molecular technologies and analytical approaches used to identify the causal gene(s) and/or variant(s) underlying rare genetic disorders. The purpose of this Notice of Fundin

   Closes in 9 daysUp to $2.3 million

   SaveCalendar
6. Closes30 OCT

   HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)

   NIH · Public colleges, Tribal organizations, Tribes, +12 more

   The NIH Helping to End Addiction Long-term ® (HEAL) Initiative is releasing this Notice of Funding Opportunity (NOFO) to support a phased mechanistic clinical research program focusing on understudied biological mechanisms that drive joint pain. The phased projects supported by this program (of up to five years total in duration) will first identify and vali

   Closes in 9 days

   SaveCalendar
7. Closes02 NOV

   Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

   NIH · States, Public colleges, Private colleges, +12 more

   This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V

   Closes in 12 days

   SaveCalendar
8. Closes02 NOV

   Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)

   NIH · Public colleges, States, Special districts, +12 more

   This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review

   Closes in 12 days

   SaveCalendar
9. Closes02 NOV

   National Indian Health Outreach and Education

   HHS · Tribal organizations, Nonprofits, Tribes, Others

   The purpose of this NOFO is to further the IHS mission and goals related to providing quality health care to the AI/AN community through outreach and education. Our focus is on promoting awareness, visibility, training, technical assistance, and education in the following components:Health education and outreach.Rural Health Transformation review and outreac

   Closes in 12 days$246,311 to $1.1 million

   SaveCalendar
10. Closes05 NOV

    Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

    NIH · States, Nonprofits, Counties, +12 more

    The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencie

    Open

    SaveCalendar
11. Closes05 NOV

    Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

    CDC · Counties, Cities and towns, Nonprofits (not 501(c)(3)), +10 more

    The focus of this notice of funding opportunity (NOFO) is to produce insights into disease detection and prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers. Timely surveillance and sentinel detection are essential for collecting actionable data. The research should:Address public he

    Open$1.8 million to $6 million

    SaveCalendar
12. Closes05 NOV

    US Travelers Health Research, Surveillance, Communication, and Outreach Network

    CDC · States, Tribal organizations, Public colleges, +10 more

    The NOFO supports CDC"s efforts to protect U.S. residents traveling internationally. The goal is to help U.S. travelers with pre-travel preparation, access to timely health information while traveling, and timely research on health conditions.The project will:Improve access to high quality travel preparation information for both healthcare providers and trav

    Open$750,000 to $1 million

    SaveCalendar
13. Closes06 NOV

    Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)

    NIH · Others

    This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered

    Open$1.9 million in total

    SaveCalendar
14. Closes06 NOV

    Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

    NIH · Nonprofits (not 501(c)(3)), Private colleges, Tribal organizations, +12 more

    Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk predict

    OpenUp to $350,000

    SaveCalendar
15. Closes09 NOV

    Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)

    NIH · Others

    Applications for a 3-year extension/renewal of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) clinical trial consortium are requested to fully meet the enrollment targets, complete participant follow-up, and finalize data analysis and dissemination of study findings. This Notice of Funding Opportunity (NOFO) invites a Single Source applicati

    Open$1.8 million in total

    SaveCalendar
16. Closes09 NOV

    Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)

    NIH · Others

    This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite an application from the eligible organization to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, applications will be peer-reviewed, and only meritorious applications will be considered for funding.

    Open$6.3 million in total

    SaveCalendar
17. Closes10 NOV

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    NIH · Tribes, School districts, Cities and towns, +12 more

    Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites grant applications proposing exploratory research projects focused on further development and technical validation of emerging technologies offering novel capabilities for the molecular or cellular characterization of cancer or for improved handling and quality con

    OpenUp to $300,000

    SaveCalendar
18. Closes10 NOV

    Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

    NIH · School districts, Others, Tribes, +12 more

    The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size popula

    Open$40 million in total

    SaveCalendar
19. Closes10 NOV

    Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)

    NIH · For-profits, Cities and towns, Housing authorities, +12 more

    The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Le

    Open$18 million in total

    SaveCalendar
20. Closes10 NOV

    Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)

    NIH · Tribal organizations, Others, Private colleges, +12 more

    This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse Brain Atlas (AD-MBA), which will serve as a central, unified rese

    Open$2.5 million in total

    SaveCalendar
21. Closes10 NOV

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    NIH · Counties, States, School districts, +12 more

    Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies offering new capabilities for the molecular or cellular characterization of cancer or for improved handling and quality control of biospecimens for basic, clinical, or epidemiological cancer research.

    OpenUp to $150,000

    SaveCalendar
22. Closes10 NOV

    Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

    NIH · Cities and towns, Others, Housing authorities, +12 more

    The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implemen

    Open$10 million in total

    SaveCalendar
23. Closes10 NOV

    Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)

    NIH · Nonprofits (not 501(c)(3)), Private colleges, Public colleges, Nonprofits

    This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with

    Open$5 million in total

    SaveCalendar
24. Closes10 NOV

    Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)

    NIH · Tribal organizations, Cities and towns, Others, +12 more

    The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and

    Open$50,000 to $100,000

    SaveCalendar
25. Closes13 NOV

    NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

    NIH · Cities and towns, Tribes, For-profits, +12 more

    This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated, early phase, clinical trials of natural products (i.e., botanicals, dietary supplements, and probiotics), which have a strong scientific premise to justify further clinical testing. For this NOFO, natural products include promising nutritional regimens that standard

    OpenUp to $1.1 million

    SaveCalendar

Showing 25 of 754, soonest first. The grant finder lists the rest.